NCT02703519

Brief Summary

This prospective, controlled, clinical, intervention study measures the number of uterine Cesarean section scars and median myometrial thickness of women who underwent two Cesarean sections six to nine months after their last Cesarean section using transvaginal ultrasound. It is the purpose of the study to assess if a resection of the uterine scar from a previous Cesarean section during a second Cesarean section could lead to a decrease in risk for subsequent pregnancies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
116

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2014

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

March 6, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 9, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

September 9, 2016

Status Verified

September 1, 2016

Enrollment Period

1.8 years

First QC Date

March 6, 2016

Last Update Submit

September 8, 2016

Conditions

Keywords

cesarean section, repeatuterine scar tissuetransvaginal ultrasounduterine ruptureplacenta accretaplacenta percretaplacenta increta

Outcome Measures

Primary Outcomes (1)

  • number of uterine Cesarean section scars using transvaginal ultrasound

    6-9 months

Secondary Outcomes (1)

  • median myometrial thickness of lower uterine segment using transvaginal ultrasound

    6-9months

Study Arms (3)

1 cesarean section

NO INTERVENTION

control group

2 cesarean sections

NO INTERVENTION

control group

resection of uterine scar tissue

EXPERIMENTAL

2 cesarean sections with resection of uterine scar tissue from first cesarean section

Procedure: resection of uterine scar tissue

Interventions

resection of uterine scar tissue of a previous cesarean section during a second cesarean section

resection of uterine scar tissue

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • primary or secondary indication for cesarean section 6 to 9 months prior to the examination date

You may not qualify if:

  • \<18 years old
  • current pregnancy
  • congenital deformity of the uterus
  • former surgery of the uterine myometrium

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Maternity Clinic/Perinatal Treatment Center, Halle University Hospital, Martin-Luther-Universität Halle-Wittenberg

Halle, Saxony-Anhalt, Germany

Location

Maternity Clinic, Magdeburg University Hospital

Magdeburg, Saxony-Anhalt, Germany

Location

MeSH Terms

Conditions

CicatrixWounds and InjuriesUterine RupturePlacenta Accreta

Condition Hierarchy (Ancestors)

FibrosisPathologic ProcessesPathological Conditions, Signs and SymptomsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesObstetric Labor ComplicationsPregnancy ComplicationsGenital DiseasesRupturePlacenta Diseases

Study Officials

  • Gregor Seliger, Dr. med.

    Maternity Clinic/Perinatal Treatment Center, Halle University Hospital, Martin-Luther-Universität Halle-Wittenberg

    PRINCIPAL INVESTIGATOR
  • Michael Tchirikov, Prof.

    Maternity Clinic/Perinatal Treatment Center, Halle University Hospital, Martin-Luther-Universität Halle-Wittenberg

    STUDY CHAIR
  • Serben-Dan Costa, Prof.

    Maternity Clinic, Magdeburg University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. med., chief resident

Study Record Dates

First Submitted

March 6, 2016

First Posted

March 9, 2016

Study Start

November 1, 2014

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

September 9, 2016

Record last verified: 2016-09

Data Sharing

IPD Sharing
Will not share

Locations